Natco Pharma stock split history
NSE: NATCOPHARMBSE: 524816Pharmaceuticals & BiotechnologySmall Cap
Last close ₹791.85up ₹6.70 (0.85%)BSE ₹792.20
Share price at the NSE close on 23 Oct 2026. Previous close ₹785.15.
52-week range of traded prices to 23 Oct 2026
₹773.60Low, 22 Oct 2026₹1,226.80High, 12 May 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹15,534 Cr380th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 13.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.57%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 13.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 8.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 5,69,53550.8% delivered
What one share became
Bonus issues and splits since Jan 2007. Neither changes what a holding is worth on the day.Natco Pharma dividend history
One share held before 26 Nov 20155 shares todayShares today for one share held before. One share multiplied by the share factor of this bonus or split and of every one after it: a 1:1 bonus doubles the count, and a split of a ₹10 share into ₹2 shares multiplies it by five.
- Face value today
- ₹2
- Splits
- 1
Stock splits: face value, ex-date and record date
A stock split, or share split, divides each share into more shares of a lower face value. On record from 2007.
Shares today for one held before the ex-date, after every event sinceShares today for one share held before. One share multiplied by the share factor of this bonus or split and of every one after it: a 1:1 bonus doubles the count, and a split of a ₹10 share into ₹2 shares multiplies it by five.
- 26 Nov 2015 · ex-dateEach share became 5, face value ₹10 to ₹2Record date 28 Nov 20155 shares todayfor 1 held before 26 Nov 2015
Buybacks and rights issues
Every one on record, latest first.
- Rights issue · 1 Oct 2026 · record date 1 Oct 20262 new shares offered for every 21 held at ₹750 a share. Open 12 Oct 2026 to 22 Oct 2026.
- Buyback · 21 Mar 2023Bought back on the exchange at up to ₹700 a share, 21 Mar 2023 to 12 May 2023.
- Buyback · 19 Nov 2018Bought back on the exchange at up to ₹1,000 a share, 19 Nov 2018 to 17 May 2019.
- Buyback · 12 Feb 2007Bought back on the exchange at up to ₹150 a share, 12 Feb 2007 to 30 Jul 2007.